Orthofix Medical Inc. OFIX Marketing Service Fees

Discontinued — last reported Q3 '16

Other financials

Revenue$196.7M+1.6%

Gross profit$139.5M+14.7%

Operating income-$14.4M+70.5%

Net income-$20.9M+60.6%

EPS (diluted)-$0.52+61.5%

Cash & equivalents$120.3M+108%

Total debt$237.5M+32.3%

Total equity$435.2M-5.0%

Total assets$886.6M+7.7%

Operating cash flow-$17.6M+4.2%

CapEx$10.7M+58.3%

Free cash flow-$28.3M-12.5%

Market cap$376.33M-7.1%

Enterprise value$493.54M-6.3%

P/S0.5×0.0×

Gross margin70.7%+3.6pp

Operating margin-5.8%-2.1pp

Net margin-7.3%-2.7pp

FCF margin-9.3%-1.7pp

Return on equity-13.4%-4.6pp

Debt / equity0.5×+0.2×

Current ratio2.9×+0.2×

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept ofix:MarketingServiceFees.

The official record: Orthofix Medical Inc.’s 10-Q, filed October 31, 2016, on SEC EDGAR. View the filing →